Literature DB >> 2502409

Chronic mucocutaneous candidiasis.

C H Kirkpatrick1.   

Abstract

Chronic mucocutaneous candidiasis can be defined as a group of syndromes that have as a common feature infections of the skin, nails and mucous membranes with Candida albicans. A variety of disorders including endocrine dysfunctions, alopecia, vitiligo, malabsorption syndromes, neoplasms and other infections may also occur in patients with chronic mucocutaneous candidiasis, but these vary considerably from patient to patient. In most patients with chronic mucocutaneous candidiasis, there are abnormalities of cell-mediated immunity. These may be limited to antigens of Candida albicans, but in some patients they are more extensive and involve the T-lymphocyte-mediated responses to all antigens. These immunologic defects are the factors that predispose patients to infections with opportunistic organisms such as Candida spp. Fungal infections in patients with chronic mucocutaneous candidiasis usually respond to treatment with conventional antifungal agents, but often relapse shortly after treatment is stopped unless the defects in the cell-mediated immune system have been corrected.

Entities:  

Mesh:

Year:  1989        PMID: 2502409     DOI: 10.1007/bf01964059

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  52 in total

1.  Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy.

Authors:  C H Kirkpatrick; T K Smith
Journal:  Ann Intern Med       Date:  1974-03       Impact factor: 25.391

2.  The susceptibility to moniliasis in children with endocrine hypofunction.

Authors:  D B Louria; D Shannon; G Johnson; L Caroline; A Okas; C Taschdjian
Journal:  Trans Assoc Am Physicians       Date:  1967

Review 3.  Transfer factor.

Authors:  C H Kirkpatrick
Journal:  J Allergy Clin Immunol       Date:  1988-05       Impact factor: 10.793

4.  Anti-pigment-cell factors and mucocutaneous candidiasis.

Authors:  J J Nordlund; N Howanitz; J C Bystryn; B M Forget; A B Lerner
Journal:  Arch Dermatol       Date:  1981-04

5.  Pubertal progression in the presence of elevated serum gonadotropins in girls with multiple endocrine deficiencies.

Authors:  A W Lucky; R W Rebar; R M Blizzard; E M Goren
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

6.  Non-candidal infections in children with chronic mucocutaneous candidiasis.

Authors:  B E Chipps; F T Saulsbury; S H Hsu; W T Hughes; J A Winkelstein
Journal:  Johns Hopkins Med J       Date:  1979-06

7.  Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy.

Authors:  J D Sobel
Journal:  N Engl J Med       Date:  1986-12-04       Impact factor: 91.245

8.  Mucocutaneous candidiasis and thymoma.

Authors:  C H Kirkpatrick; D B Windhorst
Journal:  Am J Med       Date:  1979-06       Impact factor: 4.965

9.  Candidiasis in cancer patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

10.  Dermatophytosis in patients with chronic mucocutaneous candidiasis.

Authors:  S K Shama; C H Kirkpatrick
Journal:  J Am Acad Dermatol       Date:  1980-04       Impact factor: 11.527

View more
  10 in total

Review 1.  Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.

Authors:  R D Nelson; N Shibata; R P Podzorski; M J Herron
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

2.  Detection of candidal antigens in autoimmune polyglandular syndrome type I.

Authors:  P Peterson; J Perheentupa; K J Krohn
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

3.  Production of T-helper cell subsets and cytokines by lymphocytes from patients with chronic mucocutaneous candidiasis.

Authors:  L J Kobrynski; L Tanimune; L Kilpatrick; D E Campbell; S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

Review 4.  Immunopathogenesis of recurrent vulvovaginal candidiasis.

Authors:  P L Fidel; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

5.  CD86 (B7-2), but not CD80 (B7-1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections.

Authors:  A A Gaspari; R Burns; A Nasir; D Ramirez; R K Barth; C G Haidaris
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 6.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 7.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

8.  Autoimmune hemolytic anemia in chronic mucocutaneous candidiasis.

Authors:  B I Oyefara; H C Kim; R N Danziger; M Carroll; J M Greene; S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

9.  Chronic mucocutaneous candidiasis and primary hypothyroidism in two families.

Authors:  Anne Grethe Myhre; Asbjørg Stray-Pedersen; Steinar Spangen; Eigill Eide; Dag Veimo; Per Morten Knappskog; Tore G Abrahamsen; Eystein S Husebye
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

10.  Hosting infection: experimental models to assay Candida virulence.

Authors:  Donna M Maccallum
Journal:  Int J Microbiol       Date:  2011-12-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.